(Q43787461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Milena Brunialti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Esper Georges Kallas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Carlos Alberto Zaccarelli-Filho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Erika Ono

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Daisy Maria Machado

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Regina Célia de Menezes Succi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Maria Isabel de Moraes-Pinto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

Cytometry Part B: Clinical Cytometry

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

14-21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

Measles antibody: reevaluation of protective titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

Increased expression of activation markers on CD8 lymphocytes in children with human immunodeficiency virus-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

T-cell re-population in HIV-infected children on highly active anti-retroviral therapy (HAART)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Efficacy of highly active antiretroviral therapy in HIV-1 infected children

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Identification of a human recent thymic emigrant phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Subpopulations of T and B cells in perinatally HIV-infected and noninfected age-matched children compared with those in adults.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

HIV and AIDS: 20 years of science

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Preserved immune system in long-term asymptomatic vertically HIV-1 infected children

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Immunophenotyping of T lymphocytes by three-color flow cytometry in healthy newborns, children, and adults

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Virus load correlates inversely with the expression of cytotoxic T lymphocyte activation markers in HIV-1-infected/AIDS patients showing MHC-unrestricted CTL-mediated lysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

CD5+ B cells in normal newborns and infants, and in those with HIV and intrauterine infections

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

CD4 Cell Response to Antiretroviral Therapy in Children with Vertically Acquired HIV Infection: Is It Associated with Age at Initiation?

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Long-Term Effects of Highly Active Antiretroviral Therapy in Pretreated, Vertically HIV Type 1-Infected Children: 6 Years of Follow-Up

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20152

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17041945%20AND%20SRC:MED&resulttype=core&format=json

release_uxb2yvsdofhnzogqejsfwrbka4

20 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uxb2yvsdofhnzogqejsfwrbka4

24 November 2022

mapped directly with Wikidata item

1 reference